Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

2.1K
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
2.1K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

4.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.4K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

4.9K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
4.9K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

3.2K
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
3.2K
Steps in Outbreak Investigation01:18

Steps in Outbreak Investigation

494
In the ever-evolving field of public health, statistical analysis serves as a cornerstone for understanding and managing disease outbreaks. By leveraging various statistical tools, health professionals can predict potential outbreaks, analyze ongoing situations, and devise effective responses to mitigate impact. For that to happen, there are a few possible stages of the analysis:
494
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

870
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
870

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Upfront Effectiveness of a 6-Week Continuous Glucose Monitoring Intervention for Non-Insulin-Using Individuals With Type 2 Diabetes Is No Longer Detectable at 6-12 Months: An Observational Follow-Up of a Randomized Trial Cohort.

Diabetes, obesity & metabolism·2026
Same author

In T2D inadequately controlled with metformin, orforglipron reduced HbA<sub>1c</sub> more than oral semaglutide at 52 wk.

Annals of internal medicine·2026
Same author

Impact of COVID-19-related data drift on machine-learning prognostic models predicting 30-day opioid-related emergency department visits, hospitalisation or mortality: a population-level administrative data study in Alberta, Canada.

BMJ open·2026
Same author

Tissue-resolved proteomic characterization of oat grains guided by metabolite MALDI mass spectrometry imaging.

Analytical and bioanalytical chemistry·2026
Same author

Correction: Influence of the COVID-19 pandemic on chronic disease management among indigenous people in Canada.

Frontiers in public health·2026
Same author

Resource Use Following Revascularization for Multivessel Coronary Artery Disease.

Journal of the American Heart Association·2026

Related Experiment Video

Updated: Jan 18, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.5K

Predicting the Risk of COVID-19 Among Adult Patients With Diabetes: A Machine Learning Approach.

Dean T Eurich1, Darren Lau2, Weiting Li3

  • 1School of Public Health, University of Alberta, Edmonton, Alberta, Canada.

Canadian Journal of Diabetes
|September 12, 2025
PubMed
Summary
This summary is machine-generated.

A machine learning model was developed to predict COVID-19 risk in Albertans with diabetes. The model showed high specificity but low sensitivity, limiting its clinical use for predicting severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) infection.

Keywords:
COVID-19apprentissage automatiquediabetesdiabèteepidemiologymachine learningpublic healthsanté publiqueépidémiologie

More Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Related Experiment Videos

Last Updated: Jan 18, 2026

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack
07:31

Implementation of a Real-Time Psychosis Risk Detection and Alerting System Based on Electronic Health Records using CogStack

Published on: May 15, 2020

7.5K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Area of Science:

  • Medical Informatics
  • Epidemiology
  • Machine Learning in Healthcare

Background:

  • Diabetes mellitus (type 1 and type 2) is a significant risk factor for severe COVID-19 outcomes.
  • Accurate prediction of COVID-19 acquisition risk is crucial for public health interventions, especially in vulnerable populations.
  • Alberta, Canada, has a substantial population of individuals with diabetes.

Purpose of the Study:

  • To develop and validate a machine learning model for predicting the risk of acquiring COVID-19 (SARS-CoV-2 infection) in community-dwelling adults with diabetes in Alberta.
  • To assess the performance of the Light Gradient Boost (LGBoost) model using administrative health data.

Main Methods:

  • A supervised machine learning approach was employed using administrative health data from 369,514 adults with diabetes in Alberta (April 2019-March 2021).
  • The Light Gradient Boost (LGBoost) model was trained on 67% of the data and validated on the remaining 33%, incorporating 367 features.
  • Model performance was evaluated using Area Under the Receiver-Operating Characteristic Curve (AUROC), Area Under the Precision-Recall Curve (AUPRC), and calibration analyses.

Main Results:

  • The LGBoost model achieved an AUROC of 0.69 and an AUPRC of 0.08 in predicting SARS-CoV-2 infection among individuals with diabetes.
  • The model demonstrated high specificity (≥0.98) but low sensitivity (≤0.08) and low positive predictive values (≤0.18) across all risk thresholds.
  • Despite good calibration for common risk thresholds, the model's low sensitivity limits its practical clinical utility.

Conclusions:

  • The developed LGBoost machine learning model is not sufficiently sensitive for clinical use in predicting COVID-19 (SARS-CoV-2) infection among Albertans with diabetes.
  • Alternative data sources or model architectures may be necessary to enhance the predictive accuracy and clinical utility of future COVID-19 risk prediction models in this population.